Articles related to CARDIOVASCULAR EVENTS
Landmark Pig Heart Recipient Had Xenograft Failure, Porcine Virus
The story of David Bennett, age 57, who had severe cardiac failure and was denied a traditional human heart transplant from several programs when he ultimately agreed to the experimental xenotransplant. On day 34, the patient showed no signs of rejection of the porcine heart, but by day 49, sudden diastolic thickening and antibody-mediated failure of the xenograft prevented any lifesaving measures, and he died on day 60.
Cardiology July 13th 2022
An Uncommon Cause of Chest Pain
A clinical picture of the spontaneous pneumothorax, which is considered spontaneous if there is no apparent precipitating cause and can be easily missed on a chest radiograph unless there is a strong index of clinical suspicion. This article discusses risk factors, diagnosis, and treatment for the condition.
Cardiology July 13th 2022
Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
In addition to other discoveries, the authors found that reported rates of myocarditis or pericarditis were higher after vaccination with mRNA-1273 (Moderna Spikevax) compared with BNT162b2 (Pfizer-BioNTech Comirnaty).
All Specialties July 6th 2022
Physicians Debate Statin Use for Patients with Cardiovascular Disease
In a look “Beyond the Guidelines,” a preventive cardiologist and a general internist discuss their approach in the case of a 57-year-old woman with high cholesterol and a family history of heart disease.
Cardiology June 23rd 2022
Alcohol May Be More Risky to the Heart Than Previously Thought
Although many studies have claimed that moderate alcohol consumption and drinks such as red wine can be healthy for the human heart, a new study presented at the European Society of Cardiology 2022 meeting takes a contrarian viewpoint and draws a link between alcohol consumption and heart failure in people with hypertension, diabetes, or obesity.
Cardiology May 31st 2022
Managing stage 1 hypertension: Consider the risks, stop the progression
There haven’t been any national guidelines developed for managing patients with stage 1 hypertension who don’t respond to lifestyle modification. This population represents an important guideline gap: most patients with stage 1 hypertension progress to stage 2 hypertension, which increases the risk for cardiovascular events. The AHA has published a scientific statement to fill the gap – if lifestyle modification fails to reduce blood pressure, consider pharmacotherapy.
Cardiology May 17th 2022